385 results on '"Lauss, Martin"'
Search Results
2. Molecular patterns of resistance to immune checkpoint blockade in melanoma
3. Transcriptomic signatures of tumors undergoing T cell attack
4. Author Correction: Tumour gene expression signature in primary melanoma predicts long-term outcomes
5. The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma
6. BRN2 is a non-canonical melanoma tumor-suppressor
7. Tumour gene expression signature in primary melanoma predicts long-term outcomes
8. Tertiary lymphoid structures improve immunotherapy and survival in melanoma
9. Monitoring of Technical Variation in Quantitative High-Throughput Datasets
10. 918 Functional heterogeneity of CD4+tumor-infiltrating lymphocytes
11. Escape from nonsense-mediated decay associates with anti-tumor immunogenicity
12. Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
13. Molecular patterns of resistance to immune checkpoint blockade in melanoma
14. Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival
15. Genome methylation patterns in male breast cancer – Identification of an epitype with hypermethylation of polycomb target genes
16. Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation
17. Author Correction: Tertiary lymphoid structures improve immunotherapy and survival in melanoma
18. Data Supplement from Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to Smoking History
19. Supplementary Table S10 from Prediction of Stage, Grade, and Survival in Bladder Cancer Using Genome-wide Expression Data: A Validation Study
20. 159930_1_supp_0_n72rg6.xls from Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma
21. Data from Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling
22. Supplementary Figures S1-S4 from Prediction of Stage, Grade, and Survival in Bladder Cancer Using Genome-wide Expression Data: A Validation Study
23. Supplementary Methods, Figures 3-5 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma
24. Supplementary Figure S1-S5 from Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling
25. Supplementary Figure 3 from A Molecular Taxonomy for Urothelial Carcinoma
26. Supplementary Table 4 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma
27. Data from Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma
28. Supplementary Data from Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma
29. Supplementary Text 2 from A Molecular Taxonomy for Urothelial Carcinoma
30. Supplementary Table 3 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma
31. Supplementary Figure Legends from Genome-wide DNA Methylation Analysis of Lung Carcinoma Reveals One Neuroendocrine and Four Adenocarcinoma Epitypes Associated with Patient Outcome
32. Supplementary Text 1 from A Molecular Taxonomy for Urothelial Carcinoma
33. Supplementary Figure 2 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma
34. Supplementary Methods and References from Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma
35. Supplementary Figure 1 from A Molecular Taxonomy for Urothelial Carcinoma
36. Supplementary Table 2 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma
37. Supplementary Figure 1 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma
38. Supplementary Table 1 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma
39. Supplementary Methods from Genome-wide DNA Methylation Analysis of Lung Carcinoma Reveals One Neuroendocrine and Four Adenocarcinoma Epitypes Associated with Patient Outcome
40. Supplementary Figure Legends 53 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma
41. Supplementary Figures S1-S15 from Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma
42. Supplementary Figure 2 from A Molecular Taxonomy for Urothelial Carcinoma
43. Supplementary Methods from Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling
44. Supplementary Figures 1-6 from Genome-wide DNA Methylation Analysis of Lung Carcinoma Reveals One Neuroendocrine and Four Adenocarcinoma Epitypes Associated with Patient Outcome
45. Infiltration of CD3+ and CD68+ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors
46. Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing
47. DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype
48. Toward a Molecular Pathologic Classification of Urothelial Carcinoma
49. Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
50. B Cells and Tertiary Lymphoid Structures:Friends or Foes in Cancer Immunotherapy?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.